D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$625M |
| 3 |
Merck
MRK
|
$498M |
| 4 |
Bank of America
BAC
|
$487M |
| 5 |
Fortinet
FTNT
|
$321M |
Top Sells
| 1 |
Tesla
TSLA
|
$696M |
| 2 |
Adobe
ADBE
|
$610M |
| 3 |
Accenture
ACN
|
$518M |
| 4 |
Microsoft
MSFT
|
$495M |
| 5 |
Broadcom
AVGO
|
$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Acadia Pharmaceuticals
ACAD
$4.29B
| $53.9M | 0.05% |
3,504,957
+570,031
| +19% | +$8.77M |
|
277
Amgen
AMGN
$150B
| $53.6M | 0.05% |
166,446
-140,234
| -46% | -$45.2M |
|
278
Signet Jewelers
SIG
$3.82B
| $53.6M | 0.05% |
519,691
+505,418
| +3,541% | +$52.1M |
|
279
Genpact
G
$7.72B
| $53.4M | 0.05% |
1,362,637
-344,305
| -20% | -$13.5M |
|
280
Veeva Systems
VEEV
$46.1B
| $53.4M | 0.05% |
254,434
-403,075
| -61% | -$84.6M |
|
281
Rocket Companies
RKT
$42.7B
| $53.4M | 0.05% |
2,781,568
+1,344,433
| +94% | +$25.8M |
|
282
On Holding
ONON
$14.8B
| $52.9M | 0.05% |
+1,055,680
| New | +$52.9M |
|
283
PTC Therapeutics
PTCT
$4.54B
| $52.7M | 0.05% |
1,419,539
+61,901
| +5% | +$2.3M |
|
284
Raymond James Financial
RJF
$32.9B
| $51.9M | 0.04% |
423,856
+416,460
| +5,631% | +$51M |
|
285
Liberty Broadband Class A
LBRDA
$8.53B
| $51.7M | 0.04% |
673,220
-59,426
| -8% | -$4.57M |
|
286
Zillow
Z
$21.7B
| $51.7M | 0.04% |
809,566
+649,561
| +406% | +$41.5M |
|
287
Bank OZK
OZK
$5.89B
| $51.2M | 0.04% |
1,192,047
+476,203
| +67% | +$20.5M |
|
288
Avidity Biosciences
RNA
$6.31B
| $50.9M | 0.04% |
1,108,647
+369,608
| +50% | +$17M |
|
|
DHC
289
Diversified Healthcare Trust
DHC
$1.03B
| $50.7M | 0.04% |
12,111,152
-1,023,185
| -8% | -$4.29M |
|
290
CommScope
COMM
$3.65B
| $50.6M | 0.04% |
8,278,797
+2,195,752
| +36% | +$13.4M |
|
291
SolarEdge
SEDG
$1.92B
| $50.6M | 0.04% |
2,207,250
+800,034
| +57% | +$18.3M |
|
292
Comfort Systems
FIX
$25.2B
| $50.5M | 0.04% |
129,494
-11,413
| -8% | -$4.46M |
|
293
PROG Holdings
PRG
$1.4B
| $50.5M | 0.04% |
1,040,775
+144,700
| +16% | +$7.02M |
|
294
McDonald's
MCD
$222B
| $50.2M | 0.04% |
164,704
-332,745
| -67% | -$101M |
|
295
CBRE Group
CBRE
$48.5B
| $50.1M | 0.04% |
402,749
+79,438
| +25% | +$9.89M |
|
296
Trex
TREX
$6.75B
| $50.1M | 0.04% |
752,477
+609,973
| +428% | +$40.6M |
|
297
Live Nation Entertainment
LYV
$39B
| $49.9M | 0.04% |
455,605
-161,855
| -26% | -$17.7M |
|
298
Atmus Filtration Technologies
ATMU
$3.81B
| $49.8M | 0.04% |
1,326,883
+442,425
| +50% | +$16.6M |
|
299
United Parcel Service
UPS
$70.7B
| $49.5M | 0.04% |
363,099
+251,730
| +226% | +$34.3M |
|
300
PG&E
PCG
$32.1B
| $49.4M | 0.04% |
2,498,537
+1,378,686
| +123% | +$27.3M |
|